• Welcome to the New Conservative Angle!

    We're excited to introduce a new era for our readership.

    For years, Conservative Angle has served as a clearinghouse for news, commentary, and analysis from across the conservative movement. Thousands of readers have visited these pages to stay informed, discover new voices, and keep pace with the stories shaping our nation and our world.

    Today, we are building on that foundation.

    The new Conservative Angle is more than a news aggregator. It is a community.

    Our mission remains the same: to provide access to important stories, encourage informed discussion, and promote the free exchange of ideas. But now, readers have a place to participate, share perspectives, ask questions, and openly and respectfully engage directly with fellow conservatives and independent thinkers.

    As Conservative Angle grows, we will continue adding new features, new content, and new ways for readers to participate. The site will evolve over time based on the interests, ideas, and contributions from the community.

    Whether you are a longtime visitor or discovering Conservative Angle for the first time, we invite you to become part of the conversation.

    Register for an account, introduce yourself to the community, and join the discussions that matter most to you. Together, we can create a place where news is not merely consumed, but examined, debated, and understood.

    Thank you for your patience during our transition and for your continued support.

    Welcome to the new Conservative Angle.

    — The Conservative Angle Team

DEVELOPING: FDA Issues Nationwide Recall On Crucial Medication

special-alert-breaking-news-1200x630-1.jpg

While food recalls often grab the headlines, the FDA also regulates medications and, as in one recent case, issues widespread recalls when an issue is identified.

A popular thyroid drug is the latest example, with Major Pharmaceuticals confirming that a batch of its levothyroxine sodium tablets left the factory without the sufficient level of medication.

As The Hill added:

The recall was designated a Class II on July 17, meaning the tablets may cause temporary adverse health consequences, the FDA said.

Major Pharmaceuticals packaged and distributed the recalled medication nationwide, and Cardinal Health also distributed some of it.

The recalled tablets were packaged in 10-count blister packs, sold individually or in cartons of 10 packs (100 total), the FDA added.

News of the recall soon began to spread via social media:

But the covid vaccine has killed millions and they keep on giving them

— Peter Zolintakis (@Petros438) July 28, 2026


The recalled products are Major Pharmaceuticals’ generic levothyroxine
25 mcg50 mcg75 mcg88 mcg112 mcg125 mcg150 mcg
Affected lots include, for example:
25 mcg: N02212
50 mcg: N02200
75 mcg: N02172, N02288, N02296
88 mcg: N02203
112 mcg: N02310
125 mcg: N02266
150 mcg: N02167

— Dichter Rx/Soda Shop (@MANNYRX) July 28, 2026


The recall was designated a Class II on July 17, meaning the tablets may cause temporary adverse health consequences, the FDA said.

More: https://t.co/z1s9eqUejN pic.twitter.com/tvzSE4YCkl

— WGN TV News (@WGNNews) July 28, 2026


NewsNation added these details:

The tablets were available in 25, 50, 75, 88, 112 and 150 microgram amounts with expiration dates ranging from July 2026 to January 2027.

The FDA didn’t disclose the number of tablets recalled but confirmed the recall was initiated July 13.

This announcement came on the heels of a widespread outbreak of foodborne illness, which itself was the latest in a long line of FDA recalls.

Here’s some additional commentary about the ongoing trend:

Continue reading...

[ H/T WLT Report ]

Comments

There are no comments to display
Back
Top